LFMD LIFEMD INC

LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference

LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference

NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in Sidoti’s Micro-Cap Virtual Conference taking place August 16-17, 2023. Management will be presenting a corporate overview on August 17 at 10:00am Eastern time and will be hosting one-on-one meetings with investors.

The presentation will be webcast live and available for replay in the Investors section of LifeMD’s website by clicking . To register for the conference, visit . Registration is free and investors are not required to be a Sidoti client.

About LifeMD™

LifeMD is a direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to .

Media Contact

Investor Contact

Marc Benathen, CFO



EN
02/08/2023

Underlying

LFMDLIFEMD INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Announces Closing of $50 Million Revolving Credit Facility with...

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured revolving credit facility (“RCF”) with Citizens Bank, N.A. (“Citizens”). The facility has a maturity date of January 2, 2029 and provides for up to $50 million of total availability consisting of $30 million of committed availability with an additional accordion option of up to $20 million. As of closing, no balance was dra...

January 6, 2026 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealt...

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill Adds first and only FDA‑approved oral GLP‑1 to its virtual weight management offering, expanding access to affordable, branded treatment options NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced it is Novo Nordisk’s Wegovy® (semaglutide) pill – the first and only FDA-approved oral GLP-1 therapy for chronic weight management and cardiovascular health – through its end-to-end teleh...

January 5, 2026 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on January 15, 2026, to holders of record at the close of business on January 5, 2026. About LifeMD, Inc.LifeMD® is a leading provide...

December 26, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIM...

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both the 2025 Deloitte Technology Fast 500™ and the inaugural TIME’s America’s Growth Leaders of 2026 lists. These distinguished awards reflect LifeMD’s continued revenue growth, financial stability, and emerging leadership position in the health technology sector. “Inclusion on these lists of North America...

November 24, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Reports Third Quarter 2025 Results

LifeMD Reports Third Quarter 2025 Results Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million.Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.Paid off all outstanding debt during the quarter.Subsequent to quarter end, fully divested our majority stake in WorkSimpli, positioning LifeMD as a pure-play telehealth and pharmacy platform.Continued to diversify clinical platform with new launches in women’s health, men’s health and psychiatry. Conference call begins at 4:30 p.m. East...

November 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch